Posts filtered by tags: University of Oxford[x]


 

Oxford University podcast's third season to take listeners on a journey through historical pandemics

The University of Oxford's CASE Gold Award winning podcast, Futuremakers, will return for its third season at the end of October.
Tags: Health, University of Oxford, Oxford University


Moderna just asked the FDA to authorize its coronavirus vaccine, a key step before it can be given to more people

Moderna CEO Stéphane Bancel at a meeting with President Donald Trump, members of the White House coronavirus task force, and pharmaceutical executives on March 2. Andrew Harnik/AP Images Moderna filed for emergency-use authorization of its experimental coronavirus vaccine, the company announced on Monday. The biotech company said its vaccine was 94.1% effective against COVID-19 in an analysis of a late-stage trial. If the Food and Drug Administration authorizes the vaccine, the US intends ...
Tags: White House, US, Trends, New York Times, Food And Drug Administration, Astrazeneca, Fda, Pfizer, University of Oxford, Donald Trump, Anthony Fauci, Health And Human Services, US Food and Drug Administration, Fauci, Marks, Moderna


Moderna CEO said he hopes to be vaccinating Americans 'within 24 hours' of an FDA green light

Moderna CEO Stephane Bancel attends a meeting with President Donald Trump, members of the Coronavirus Task Force, and pharmaceutical executives in the Cabinet Room of the White House on March 2, 2020. Andrew Harnik/AP Images Moderna announced it will file for emergency use-authorization with the US Food and Drug Administration on Monday. CEO Stéphane Bancel said the company aims to start vaccinating Americans within "24 hours after the FDA gives an approval." Moderna said the vaccine was 9...
Tags: News, White House, US, Trends, Healthcare, Astrazeneca, Fda, Pfizer, University of Oxford, Donald Trump, Fox Business, Johnson Johnson, US Food and Drug Administration, Department of Health and Human Services, Andrew Harnik, Moderna


3 coronavirus vaccines so far seem to prevent COVID-19. Here's how their efficacy compares to vaccines for flu, measles, and more.

A healthcare worker injects a patient with the Pfizer and BioNTech coronavirus vaccine during the phase 3 trial in Turkey in October. Dogukan Keskinkilic/Anadolu Agency via Getty Images AstraZeneca reported last week that its coronavirus vaccine candidate was 70% effective, on average, in preventing COVID-19 in clinical trials. Moderna and Pfizer's vaccine candidates were found to be 94% and 95% effective, respectively.  The chart below shows how the efficacy of those vaccine candidates co...
Tags: Health, UK, Science, News, Massachusetts, Trends, Turkey, MMR, Food And Drug Administration, Brazil, Astrazeneca, Fda, Pfizer, University of Oxford, Pascal Soriot, Johnson Johnson


How AstraZeneca and Oxford blew their vaccine moment

Hollis Johnson/Business Insider Hello,Hope you all had restful — if not abnormal — holidays. I spent this weekend getting some fresh air out here in Denver. Have any winter-time hikes I should add to my list? Let me know — I'm at [email protected] first thing this morning: Moderna is planning to file for its emergency use authorization today, a key step in getting the vaccine into the arms of more people. In an update to its late-stage trial, Moderna found that its shot was 9...
Tags: Google, Trends, Bloomberg, Oxford, Astrazeneca, Pfizer, University of Oxford, Denver, Wall Street Journal, Business Insider, Hollywood Florida, Lisa Taylor, Joe Raedle Getty, Hollis Johnson, Moderna, Cincinnati Children 's Hospital


UK adds 2 million doses of Moderna's COVID-19 vaccine, upping stockpile to 357 million doses

In the UK frontline workers are expected to be first in line to receive the Moderna vaccine. Moderna; Samantha Lee/Business Insider The UK government said on Sunday it added 2 million Moderna COVID-19 vaccine doses to its stockpile, bringing the total to 357 million, according to a press release.   The prime minister, Boris Johnson, appointed Nadhim Zahawi, minister for business and industry, to oversee the vaccine rollout. Johnson is also urging ministers to approve a new lockdown system,...
Tags: Health, Politics, UK, Trends, Healthcare, Astrazeneca, Boris Johnson, Pfizer, University of Oxford, Johnson, Vaccines, Reuters, Sanofi, GSK, Novavax, Matt Hancock


Pfizer's COVID-19 vaccine is reportedly being flown by United Airlines chartered flights to distribution hubs, in anticipation of FDA approval

Oil markets surged in the hours after Pfizer announced positive results from its coronavirus vaccine study. Dado Ruvic/Reuters Chartered United Airlines flights from Brussels to Chicago are carrying Pfizer's COVID-19 vaccine, according to The Wall Street Journal. The flights represent one leg of a chain, which will extend from Chicago to distribution hubs around the US. Pfizer's vaccine must be stored in minus -103 degrees Fahrenheit, so the flights reportedly have special FAA approval to ...
Tags: UK, US, Trends, Cnn, Chicago, NHS, Astrazeneca, Fda, Brussels, Pfizer, University of Oxford, Faa, Wall Street Journal, United, WSJ, United Airlines


Stocks rise on Wall Street as S&P 500 hits record high

The S&P 500 rose to a record high Friday as investors continue to look forward to the distribution of a COVID-19 vaccine and relief for the global economy. The benchmark index rose 8.70 points, or 0.2%, led by gains in technology companies, and closed at an all-time high of 3,638.35. The Nasdaq also closed at a record helped by gains in Apple, Tesla, Zoom and other tech companies. Positive developments on the vaccine front have driven double-digit gains in the major indexes this month as investo...
Tags: Apple, Asia, Hong Kong, Business, News, Microsoft, Etsy, France, Germany, Tech, Tesla, Walmart, Sport, Economy, Soccer, Oxford


A UK government unit has reportedly demanded the British flag should be printed on Oxford vaccine doses

A dummy coronavirus vaccine placed in front of the British flag. Pavlo Gonchar/SOPA Images/LightRocket via Getty Images The UK government's "Union Unit" has reportedly insisted Oxford's COVID-19 vaccine doses are labeled with the UK flag, the HuffPost reported Friday. People familiar with the matter said there were no plans for the UK flag to be printed on the vaccine doses, but didn't deny the request was made. The plan was reportedly strongly supported by the health secretary, Matt Hanco...
Tags: UK, US, Trends, Labour, Oxford, Astrazeneca, University of Oxford, Jack, HuffPost, Alok Sharma, Matt Hancock, Ged Killen, Kate Duffy, Pavlo Gonchar, Union Unit, Alok Sharma Manufacturers


Different age groups may get different Covid vaccines, experts say

Oxford/AstraZeneca planning new trial of lower-dose jab to see how well it works in older peopleCoronavirus – latest updatesSee all our coronavirus coverageConcerns around the efficacy of the Oxford University/AstraZeneca coronavirus jab in older people could lead to different age groups being given different vaccines, experts have said.The partners announced last week that the vaccine had a 70% efficacy overall. For most trial participants – given two full doses, spaced a month apart – the effi...
Tags: Health, Business, Science, Education, Society, World news, Medical Research, Infectious Diseases, Higher Education, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, University of Oxford, Coronavirus, Oxford University AstraZeneca, Oxford AstraZeneca


Stocks trade higher, shrugging off AstraZeneca vaccine concerns, while traders take profit in oil and Bitcoin

Traders work on the trading floor of the Frankfurt Stock Exchange. Thomas Lohnes/Getty Images European shares rose but caution prevailed after hitch in AstraZeneca's COVID-19 vaccine trial. Bitcoin hits profit-taking after massive rally this week – a fall below $16,000 risks "FOMO destruction," one analyst said. Oil eases below this week's high as wariness over the demand outlook resurfaces. Visit Business Insider's homepage for more stories. European shares traded cautiously higher on Fri...
Tags: Europe, UK, England, France, White House, Germany, US, Trends, Spain, Joe Biden, Frankfurt, Bitcoin, Paris, Shanghai, Deutsche Bank, Astrazeneca


Oxford University podcast returns with season on the History of Pandemics

The University of Oxford's CASE Gold Award winning podcast, Futuremakers, will return for its third season at the end of October.
Tags: Science, University of Oxford, Oxford University


Novel early-warning framework for evaluating control and elimination of SARS-CoV-2 in NZ

Researchers from the Imperial College London and the University of Oxford recently proposed a new framework for de-noising inter-wave data, showing how timely introduction of NPIs in New Zealand achieved local epidemic elimination and avoided dangerous resurgence of infection.
Tags: Health, New Zealand, University of Oxford, Imperial College London, Nz


China's Sinopharm has applied for regulatory approval to launch a COVID-19 vaccine for public use, but nearly 1 million people have already taken experimental shots

Ng Han Guan/ASSOCIATED PRESS Chinese pharmaceutical giant Sinopharm on Tuesday applied to the country's health regulators to launch its COVID-19 vaccines for public use, based on multiple news reports.  However, close to a million people have already been injected with experimental shots since the Chinese government authorized the vaccines for emergency use in July.  The rush to access these experimental shots has spurred fears of a booming black market for vaccines, Bloomberg News report...
Tags: China, Trends, Bloomberg, Astrazeneca, Pfizer, Alipay, University of Oxford, Pascal Soriot, Bloomberg News, Moderna, Ng Han Guan, Sinopharm, Alibaba Sinopharm, Vicky Ge Huang


AstraZeneca will likely retest its COVID-19 vaccine, CEO says after admitting an error in the first trial that may have skewed results

A man walking past an AstraZeneca sign in Macclesfield, England. Phil Noble/Reuters The UK pharmaceutical company AstraZeneca is likely to run a second global trial to assess its COVID-19 vaccine's efficacy, its CEO told Bloomberg News on Thursday. AstraZeneca and the University of Oxford announced Monday that preliminary results indicated their two-dose vaccine could be up to 90% effective at preventing COVID-19. But the team later said an error in the trial left some participants with...
Tags: Health, UK, Science, News, Politico, US, Trends, South Africa, Brazil, Astrazeneca, Pfizer, University of Oxford, Pascal Soriot, Bloomberg News, Moderna, Siphiwe Sibeko


AstraZeneca will likely re-test its COVID-19 vaccine, CEO says after admitting an error in the first trial that may have skewed results

A man walks past a sign at an AstraZeneca site in Macclesfield, UK. Phil Noble/Reuters UK pharmaceutical company AstraZeneca will likely run a second global trial to assess its COVID-19 vaccine's efficacy, the CEO told Bloomberg News on Thursday. AstraZeneca and the University of Oxford announced Monday that preliminary results showed their two-dose vaccine could be up to 90% effective at preventing COVID-19. But the team later admitted that there was an error in the trial, leaving some...
Tags: Health, UK, Science, News, US, Trends, Brazil, Astrazeneca, Pfizer, University of Oxford, Pascal Soriot, Bloomberg News, Soweto South Africa, Moderna, Siphiwe Sibeko, Sheila Bird


Dosing Mix-up Raises Questions About Promising Covid-19 Vaccine

A manufacturing error is raising concerns about a promising covid-19 vaccine being developed by pharmaceutical company AstraZeneca and the University of Oxford.Read more...
Tags: Science, Astrazeneca, University of Oxford, Vaccines, Pandemic, Coronavirus, Covid 19


AstraZeneca says it will likely do another study of COVID-19 vaccine after accidental lower dose shows higher efficacy

AstraZeneca’s CEO told Bloomberg that the pharmaceutical company will likely conduct another global trial of the effectiveness of its COVID-19 vaccine trial, following the disclosure that the more effective dosage in the existing Phase 3 clinical trial was actually administered by accident. AstraZeneca and its partner the University of Oxford reported interim results that showed 62% efficacy for a full two-dose regimen, and a 90% efficacy rate for a half-dose followed by a full dose – which t...
Tags: Health, TC, Tech, Bloomberg, Ceo, Medical Research, United States, Oxford, Astrazeneca, Fda, Pfizer, Vaccine, University of Oxford, Oxford University, Biotech, Vaccines


Oxford/AstraZeneca vaccine to undergo new global trial

Share price drops as critics question claim vaccine could protect up to 90% of peopleWhat tier am I in? Latest Covid rules in England post-lockdownCoronavirus – latest updatesSee all our coronavirus coverageThe Oxford University/AstraZeneca vaccine will undergo a new global trial as critics questioned the claim that it could protect up to 90% of people against coronavirus.On Thursday Sir John Bell, Oxford’s regius professor of medicine and the UK government’s life sciences adviser, dismissed sug...
Tags: Health, UK, England, Science, UK News, World news, Medical Research, Vaccines and immunisation, University of Oxford, Lancet, Coronavirus, Oxford University AstraZeneca, Oxford AstraZeneca, John Bell Oxford


AstraZeneca admits the best results in its COVID-19 vaccine study came from a dosing error, and experts are raising new questions about the shot

Steve Parsons-WPA Pool/Getty Images AstraZeneca and the University of Oxford are facing criticism over their COVID-19 vaccine trial results after admitting a mistake in the vaccine dosage. During the trial, some patients got two full doses of the vaccine, whilst others had a half-dose in their first shot, followed by a full dose. An AstraZeneca executive on Wednesday described the "mistake" as "serendipity": The vaccine was 90% effective in the group with the initial half-dosage, compared...
Tags: UK, New York, US, Trends, Britain, South Africa, New York Times, Food And Drug Administration, Brazil, Astrazeneca, University of Florida, Pfizer, University of Oxford, Times, Reuters, John Moore


6 crucial questions about AstraZeneca's vaccine

Welcome to Business Insider's daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday. Hollis Johnson/Business Insider Hello,Happy day-before-Thanksgiving! It's seeming like a pretty good time to log off and relax. For those looking for some holiday specific content, I was reminiscing this morning on some of my classic early BI stories. They include such gems as: how to have a (nutritionally) ...
Tags: Cdc, Trends, Getty Images, Healthcare, Oxford, Astrazeneca, Pfizer, Vaccine, University of Oxford, Oxford University, Business Insider, Cb Insights, Soweto South Africa, Moderna, Andrew Dunn, Jenner Institute


What we know about AstraZeneca’s head-scratching vaccine results

Researchers at the University of Oxford built the vaccine using a kind of virus, called an adenovirus, that typically causes colds in chimpanzees. They genetically altered the virus so that it carried a gene for a coronavirus protein, which would theoretically train a person’s immune system to recognize the real coronavirus.
Tags: Astrazeneca, University of Oxford


6 crucial unanswered questions about AstraZeneca's coronavirus vaccine results

A lower initial dose of the Oxford-AstraZeneca vaccine, would mean double the number of vaccine doses available, once regulators approve it. VINCENZO PINTO/AFP via Getty Images For the third consecutive Monday, a drugmaker said its coronavirus vaccine candidate was successful in late-stage studies. AstraZeneca and the University of Oxford said their two-dose shot was effective at preventing COVID-19, according to preliminary results.  AstraZeneca's news follows similar announcements of suc...
Tags: Health, UK, Science, US, Trends, Getty Images, Analysis, Healthcare, Oxford, Brazil, Astrazeneca, Pfizer, University of Oxford, Biotech, Afp, Pollard


Scientists are puzzling over one crucial number as they evaluate the Oxford-AstraZeneca coronavirus vaccine

Oxford-AstraZeneca's vaccine could be given at half-dose initially. VINCENZO PINTO/AFP via Getty Images The Oxford-AstraZeneca vaccine candidate is 70% effective, on average, according to a press release published on Monday. The vaccine is given as two shots. Efficacy increased to 90% in a smaller group of volunteers who received a half dose in the first shot, then a full dose in the second shot. Experts including Dr. Anthony Fauci, director of the National Institute of Allergy and Inf...
Tags: UK, US, Trends, Britain, South Africa, Oxford, Cambridge, Astrazeneca, Pfizer, University of Oxford, Pascal Soriot, Anthony Fauci, Sarah Gilbert, Gilbert, Fauci, Pollard


Vegans 43% more likely to suffer broken bones than meat eaters, Oxford study finds

A study by academics at the University of Oxford found that vegans have more than double the risk of suffering a broken hip than meat...
Tags: Oxford, University of Oxford


Moderna's chief medical officer says that vaccine trial results only show that they prevent people from getting sick — not necessarily that recipients won't still be able to transmit the virus

Lab tech Sendy Puerto processes blood samples from Moderna's coronavirus vaccine clinical trials study participants September 2, 2020 in Miami, Florida. Taimy Alvarez/AP Moderna Chief Medical Officer Tal Zaks told Axios that the public should not "over-interpret" the vaccine trial results to assume life could go back to normal after adults are vaccinated. "They do not show that they prevent you from potentially carrying this virus transiently and infecting others," Zaks told Axios.  Wh...
Tags: Science, News, US, Trends, Healthcare, Food And Drug Administration, Astrazeneca, Fda, Vaccine, University of Oxford, Miami Florida, Zaks, Moderna, Axios, Moncef Slaoui, Coronavirus


Moderna's chief medical officer says that vaccine trial results only show that they prevent people from getting severely sick — not necessarily that recipients won't still be able to transmit the virus

Lab tech Sendy Puerto processes blood samples from Moderna's coronavirus vaccine clinical trials study participants September 2, 2020 in Miami, Florida. Taimy Alvarez/AP Moderna Chief Medical Officer Tal Zaks told Axios that the public should not "over-interpret" the vaccine trial results to assume life could go back to normal after adults are vaccinated. "They do not show that they prevent you from potentially carrying this virus transiently and infecting others," Zaks told Axios.  Wh...
Tags: Science, News, US, Trends, Food And Drug Administration, Astrazeneca, Fda, Vaccine, University of Oxford, Miami Florida, Zaks, Moderna, Axios, Moncef Slaoui, Coronavirus, COVID


The creator of AstraZeneca's coronavirus vaccine is a mom to triplets. Her children participated in the trial.

Sarah Gilbert (top left), chief investigator of the Oxford coronavirus vaccine trial, speaks with Prince William (bottom right). AstraZeneca/Reuters AstraZeneca and the University of Oxford announced Monday that their COVID-19 vaccine was 70% effective, on average. The vaccine's creator, Sarah Gilbert, had faith in its efficacy from the start: Her triplets participated in the UK trial. "This vaccine should do what we always wanted it to do," Gilbert said on Monday. "We wanted a vaccine for...
Tags: UK, Science, News, US, Trends, Bloomberg, Bbc, Middle East, Oxford, Food And Drug Administration, Brazil, Astrazeneca, Pfizer, University of Oxford, William, MERS


Oxford-AstraZeneca’s Covid-19 Vaccine Up to 90% Effective

Preliminary results from the trials of the Covid-19 vaccine jointly developed by the University of Oxford and AstraZeneca indicate that the vaccine’s overall efficacy is 70% but that a regimen that calls for a lower first dose is 90% effective. The preliminary results on the AstraZeneca vaccine were based on a total of 131 Covid-19 cases in a study involving 11,363 participants. The findings were perplexing. Two full doses of the vaccine appeared to be only 62% effective at preventing disease, ...
Tags: Astrazeneca, Pfizer, University of Oxford, Jason Kottke, Moderna, Oxford AstraZeneca


Oxford Covid vaccine hit 90% success rate thanks to dosing error

Participants given first shot at half strength by mistake were found to be better protectedCoronavirus – latest updatesSee all our coronavirus coverageThe Oxford University and AstraZeneca vaccine trials reached 90% efficacy by accident thanks to the “serendipity” of an error that led to some participants receiving half-doses, it has emerged.On Monday scientists revealed that the Oxford vaccine had an overall efficacy of 70%, but could be around 90% effective when administered as a half dose fol...
Tags: UK News, Oxford, Astrazeneca, Vaccines and immunisation, University of Oxford, Oxford University, Coronavirus